Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
TUB-040 by Tubulis for Non-Small Cell Lung Cancer: Likelihood of Approval
TUB-040 is under clinical development by Tubulis and currently in Phase II for Non-Small Cell Lung Cancer. According to GlobalData,...
Data Insights
TUB-040 by Tubulis for Ovarian Cancer: Likelihood of Approval
TUB-040 is under clinical development by Tubulis and currently in Phase II for Ovarian Cancer. According to GlobalData, Phase II...